Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.4.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.75.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.37 (Lambda)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.8.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.87 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XNEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.111 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.560EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.610EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.10 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.286EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used